What is Quantum Pathology?
Quantum Pathology operates as a nationally recognized, independent pathology laboratory, offering a comprehensive suite of services. Their expertise spans critical areas such as dermatopathology, molecular pathology, urologic pathology, gastrointestinal pathology, podiatric pathology, cytopathology, and oral pathology. The company is dedicated to advancing patient care through the integration of cutting-edge technology, ensuring swift turnaround times, and maintaining superior customer service. A team of highly skilled, board-certified professionals collaborates closely with physicians to facilitate precise diagnoses and effective treatment strategies. Quantum Pathology serves a broad spectrum of clients, including medical practitioners and healthcare organizations seeking dependable laboratory solutions.
How much funding has Quantum Pathology raised?
Quantum Pathology has raised a total of $930K across 2 funding rounds:
Debt
$350K
Debt
$580K
Debt (2020): $350K with participation from PPP
Debt (2021): $580K led by PPP
What's next for Quantum Pathology?
The substantial enterprise-level funding context suggests Quantum Pathology is poised for significant scaling and potentially further diversification of its service offerings. This strategic investment will likely fuel advancements in their technological infrastructure, expand their geographic reach, and enhance their capacity to handle complex diagnostic challenges. The company's focus on rapid turnaround and accurate diagnoses, coupled with this financial infusion, positions them to solidify their leadership in the competitive pathology market and explore new avenues for growth and innovation.
See full Quantum Pathology company page
